XML 29 R12.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2024
Stockholders' Equity  
Stockholders' Equity

Earnings Per Share 

Basic earnings per share has been computed by dividing earnings available to common stockholders by the weighted average number of common shares outstanding during the respective period. Diluted earnings per share has been computed by dividing diluted earnings by the weighted average shares outstanding during the respective period, after adjusting for the potential dilution of options to purchase the Company's Common Stock, assumed vesting of restricted stock and the assumed conversion of the Company's convertible debt.  

The following table provides the computation of diluted weighted average number of common shares outstanding:   

 


 

Year Ended December 31,




 

2024 


 


2023 


 


2022 


Computation of diluted earnings:











Net income attributable to Euronet Worldwide, Inc. stockholders
$ 306.0

$ 279.7

$ 231.0
Add: Interest expense from assumed conversion of convertible notes, net of tax

4.2


4.2


4.7
Net income for diluted earnings per share calculation
$ 310.2

$ 283.9

$ 235.7













Computation of diluted weighted average shares outstanding:


 

 


 


 


 


 


Basic weighted average shares outstanding


 

44,896,711


 


48,482,006


 


50,175,614


Incremental shares from assumed exercise of stock options and vesting of restricted stock


 

404,237


 


335,809


 


505,876


Incremental shares from assumed conversion of convertible debt

2,781,818.0



2,781,818



2,781,818

Diluted weighted average shares outstanding


 

48,082,766


 


51,599,633


 


53,463,308


The table includes all stock options and restricted stock that are dilutive to the Company's weighted average common shares outstanding during the period. The calculation of diluted earnings per share excludes stock options or shares of restricted stock that are anti-dilutive to the Company's weighted average common shares outstanding for the years ended December 31, 2024, 2023 and 2022 of approximately 3,125,0003,768,000 and 1,975,000, respectively.  

We issued Convertible Senior Notes ("Convertible Notes") due March 2049 on March 18, 2019. Our Convertible Notes currently have a settlement feature requiring us upon conversion to settle the principal amount of the debt and any conversion value in excess of the principal value ("conversion premium"), for cash or shares of our common stock or a combination thereof, at our option. We have stated our intent to settle any conversion of these notes by paying cash for the principal value and issuing common stock for any conversion premium; however, after adopting ASU 2020-06, 2.8 million incremental shares assumed for conversion of convertible notes shall be included in the dilutive earnings per share calculation, if dilutive, regardless of whether the market price trigger has been met. Therefore, our Convertible Notes were included in the calculation of diluted earnings (loss) per share if their inclusion was dilutive. The dilutive effect increases the more the market price exceeds the conversion price of $188.73 per share. See Note 12, Debt Obligations, to the Consolidated Financial Statements for more information about the Convertible Notes.  

Share repurchases

The repurchase program, initiated on September 13, 2022, to repurchase up to $350 million in value, but not more than 7.0 million shares of common stock through September 13, 2024, has been completed. During 2024, we repurchased 850,528 shares under the repurchase program at a weighted average purchase price of $113.63 for a total value of $96.6 million. 


On September 13, 2023, the Company initiated a repurchase program to repurchase up to $350 million in value, but not more than 7.0 million shares of common stock through September 13, 2025. During 2024, we repurchased 1,625,005 shares under the repurchase program at a weighted average purchase price of $103.73 for a total value of $168.6 million. 


On September 11, 2024, the Company initiated a repurchase program to repurchase up to $350 million in value, but not more than 7.0 million shares of common stock through September 11, 2026. During 2024, the Company did not repurchase shares under this plan.


Repurchases under the programs may take place in the open market or in privately negotiated transactions, including derivative transactions, and may be made under a Rule 10b5-1 plan.


The Inflation Reduction Act (IRA) was signed into law in August 2022. Among other things, it imposes a 1% excise tax on net share repurchases.


Preferred Stock


The Company has the authority to issue up to 10 million shares of preferred stock, of which no shares are currently issued or outstanding.


Accumulated other comprehensive gain (loss)


As of December 31, 2024 and 2023, accumulated other comprehensive gain (loss) consists entirely of foreign currency translation adjustments. The Company recorded a foreign currency translation loss of $117.8 million, a gain of $47.9 million and a loss of $78.3 million for the years ended December 31, 2024, 2023, and 2022, respectively. There were no reclassifications of foreign currency translation into the Consolidated Statements of Operations for the years ended December 31, 2024, 2023, and 2022.


Dividends


No dividends were paid on any class of the Company's stock during 2024, 2023, and 2022.